{
    "title": "Engineered Extracellular Vesicles Modified by Angiopep-2 Peptide Promote Targeted Repair of Spinal Cord Injury and Brain Inflammation.",
    "doc_id": "39853366",
    "writer": "Kong G",
    "year": "2025",
    "summary": "Through single-cell sequencing and immunofluorescence experiments, we confirmed that the expression of LRP-1, the targeted receptor of Ang2, was elevated after spinal cord injury. Subsequently, we integrated the Ang2 peptide segment into M2 microglia to obtai â€¦",
    "abstract": "Engineered extracellular vesicles play an increasingly important role in the treatment of spinal cord injury. In order to prepare more effective engineered extracellular vesicles, we biologically modified M2 microglia. Angiopep-2 (Ang2) is an oligopeptide that can target the blood-brain barrier. Through single-cell sequencing and immunofluorescence experiments, we confirmed that the expression of LRP-1, the targeted receptor of Ang2, was elevated after spinal cord injury. Subsequently, we integrated the Ang2 peptide segment into M2 microglia to obtain Ang2-EVs, which could successfully target the site of spinal cord injury. However, in order to improve the function of Ang2-EVs, we pretreated M2 microglia with melatonin, which has anti-inflammatory effects, to obtain M-Ang2-EVs. The results of single-nucleus sequencing of the mouse spinal cord verified that neurons and OPCs gradually transformed into subtypes related to nerve repair functions after treatment with M-Ang2-EVs. This is consistent with the sequencing and enrichment analysis of miRNAs contained in M-Ang2-EVs. We further verified through experiments that M-Ang2-EVs can promote microglia/macrophages to phagocytose sphingomyelin, promote axon remyelination and axon elongation, and maintain the integrity of the blood-spinal barrier. Since Ang2 can also target the blood-brain barrier, we found that M-Ang2-EVs can also reduce brain inflammation that results from spinal cord injury. Our study applied the Angiopep-2 peptide to spinal cord injury to enhance the targeting of injured cells, and successfully construct engineered extracellular vesicles that can target the spinal cord injury site and the brain.",
    "link": "https://pubmed.ncbi.nlm.nih.gov/39853366/",
    "clean_text": "engineered extracellular vesicles modified by angiopep peptide promote targeted repair of spinal cord injury and brain inflammation through single cell sequencing and immunofluorescence experiments we confirmed that the expression of lrp the targeted receptor of ang was elevated after spinal cord injury subsequently we integrated the ang peptide segment into m microglia to obtai engineered extracellular vesicles play an increasingly important role in the treatment of spinal cord injury in order to prepare more effective engineered extracellular vesicles we biologically modified m microglia angiopep ang is an oligopeptide that can target the blood brain barrier through single cell sequencing and immunofluorescence experiments we confirmed that the expression of lrp the targeted receptor of ang was elevated after spinal cord injury subsequently we integrated the ang peptide segment into m microglia to obtain ang evs which could successfully target the site of spinal cord injury however in order to improve the function of ang evs we pretreated m microglia with melatonin which has anti inflammatory effects to obtain m ang evs the results of single nucleus sequencing of the mouse spinal cord verified that neurons and opcs gradually transformed into subtypes related to nerve repair functions after treatment with m ang evs this is consistent with the sequencing and enrichment analysis of mirnas contained in m ang evs we further verified through experiments that m ang evs can promote microglia macrophages to phagocytose sphingomyelin promote axon remyelination and axon elongation and maintain the integrity of the blood spinal barrier since ang can also target the blood brain barrier we found that m ang evs can also reduce brain inflammation that results from spinal cord injury our study applied the angiopep peptide to spinal cord injury to enhance the targeting of injured cells and successfully construct engineered extracellular vesicles that can target the spinal cord injury site and the brain"
}